GO,Description,_LogP_1d-VL_I_(VVIaVIb),_LogP_3d-VL_I_(VVIaVIb),_LogP_7d-VL_I_(VVIaVIb)
GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,0.0,-3.640685332505558,0.0
WP1270,Endochondral ossification,0.0,-3.4995133455445484,0.0
GO:0010942,positive regulation of cell death,0.0,-3.5737194957614395,0.0
GO:2000310,regulation of NMDA receptor activity,0.0,-3.4258991036340256,0.0
GO:0032922,circadian regulation of gene expression,0.0,-2.1906517513546615,0.0
GO:1901888,regulation of cell junction assembly,0.0,-2.214316751894472,0.0
GO:0009749,response to glucose,0.0,-2.582487424900892,0.0
GO:0001568,blood vessel development,0.0,-2.6217556004988474,0.0
GO:0051272,positive regulation of cellular component movement,0.0,-2.798696294224028,0.0
GO:0051056,regulation of small GTPase mediated signal transduction,0.0,-2.839853466796397,0.0
GO:0051090,regulation of DNA-binding transcription factor activity,0.0,-2.0993427604564605,0.0
GO:0035493,SNARE complex assembly,0.0,-4.3093559980481615,0.0
GO:0010996,response to auditory stimulus,0.0,-5.079166201469686,0.0
GO:0021957,corticospinal tract morphogenesis,0.0,-4.784627431373777,0.0
GO:0048168,regulation of neuronal synaptic plasticity,0.0,-4.416131003891321,0.0
GO:0035094,response to nicotine,0.0,-4.693954385659384,0.0
CORUM:2835,Profilin 2 complex,0.0,-4.937866301182713,0.0
GO:0014888,striated muscle adaptation,0.0,-6.409561383259112,0.0
GO:0055067,monovalent inorganic cation homeostasis,0.0,-6.012220564776919,0.0
R-MMU-112313,Neurotransmitter uptake and metabolism In glial cells,0.0,-6.2517646827311255,0.0
WP2432,Spinal cord injury,-3.9135174832655077,-3.756243356872094,0.0
GO:0120035,regulation of plasma membrane bounded cell projection organization,-3.0159450618931287,-3.279551624332221,0.0
GO:0071407,cellular response to organic cyclic compound,-3.9239191525618264,-3.646375575763904,0.0
WP553,Calcium regulation in cardiac cells,-2.2390368139793035,-3.899337711317416,0.0
GO:0007612,learning,-2.667252038341362,-5.204917417976783,0.0
mmu04724,Glutamatergic synapse,-4.726130590855217,-4.536023486887016,0.0
mmu04924,Renin secretion,-5.726158383238302,-2.125788551994542,0.0
GO:0030198,extracellular matrix organization,-2.6553584099083536,0.0,0.0
GO:0031099,regeneration,-2.7187761102927563,0.0,0.0
GO:0060688,regulation of morphogenesis of a branching structure,-2.3892211397107403,0.0,0.0
R-MMU-948021,Transport to the Golgi and subsequent modification,-2.0206919746124514,0.0,0.0
GO:0042063,gliogenesis,-2.8650245297617185,0.0,0.0
WP163,Cytoplasmic ribosomal proteins,-2.924096898196709,0.0,0.0
GO:0001666,response to hypoxia,-2.521805897235966,0.0,0.0
GO:0021537,telencephalon development,-2.0753998779941027,0.0,0.0
GO:0048871,multicellular organismal homeostasis,-3.2509088260765395,0.0,0.0
WP2140,Serotonin and anxiety-related events,-4.512413437922022,0.0,0.0
GO:0003094,glomerular filtration,-4.313837980074,0.0,0.0
GO:0019935,cyclic-nucleotide-mediated signaling,-2.810881146606954,0.0,-2.7984780996784755
GO:0048662,negative regulation of smooth muscle cell proliferation,0.0,-2.2246049885304124,-3.4080322593018053
GO:0019752,carboxylic acid metabolic process,0.0,-2.0317168093539912,-3.266163298222258
R-MMU-6798695,Neutrophil degranulation,0.0,-2.3088392432473666,-3.0946024948980178
GO:0043524,negative regulation of neuron apoptotic process,0.0,-4.201282772249498,-2.618221081062618
GO:0044788,modulation by host of viral process,0.0,0.0,-3.211353822179475
GO:0051900,regulation of mitochondrial depolarization,0.0,0.0,-3.844389609767526
GO:0007263,nitric oxide mediated signal transduction,0.0,0.0,-4.396292255592517
GO:0007009,plasma membrane organization,0.0,0.0,-2.309213363377162
GO:0098739,import across plasma membrane,-7.434330243266781,-3.9319890950081544,-4.093431151399009
GO:0051046,regulation of secretion,-6.8549920827611786,-5.660260524139073,-4.057637411942774
GO:0019932,second-messenger-mediated signaling,-4.520176210837558,-3.398275411008165,-4.492201674465222
GO:1902947,regulation of tau-protein kinase activity,-4.624821375479664,-4.524711080879406,-4.611868798237622
GO:0010817,regulation of hormone levels,-6.991584666441453,-3.6977448778356576,-3.9589586322824903
R-MMU-70263,Gluconeogenesis,-3.223959944361241,-4.530748360762044,-6.19363382999951
mmu04978,Mineral absorption,-3.8609564241094576,-3.732018508437979,-9.659093528527686
GO:0031175,neuron projection development,-2.4950939168196085,-9.639607694698139,-4.819606776954749
GO:0060627,regulation of vesicle-mediated transport,-3.0820866928708948,-6.106048201030127,-5.001817648153726
R-MMU-112315,Transmission across Chemical Synapses,-3.50301650009858,-10.707012394001131,-7.525877903222247
GO:0050890,cognition,-5.8825283625213105,-11.280208794001801,-4.180090106801713
GO:0050804,modulation of chemical synaptic transmission,-5.321957357002125,-15.052825734254998,-3.9338787654419414
GO:0043269,regulation of ion transport,-5.483424580367064,-7.170402162588669,-4.115474442713187
GO:0010038,response to metal ion,-3.2431273251263013,-5.478188414890879,-2.489524903909628
GO:1902430,negative regulation of amyloid-beta formation,-3.922613884211325,-5.487185364977453,-3.9097876910576796
GO:0003012,muscle system process,-2.8650245297617185,-5.177930347823574,-2.1136488395066313
GO:0097120,receptor localization to synapse,-2.6369406481427236,-5.029438565409793,-2.624646431960145
GO:1900271,regulation of long-term synaptic potentiation,-2.5697536219403365,-4.9129810254282855,-2.5575059354258127
R-MMU-76005,Response to elevated platelet cytosolic Ca2+,-2.55250558710745,-3.368407437787382,-4.553370225784856
GO:0007626,locomotory behavior,-2.795262461837831,-5.989156766386832,-4.404602261156911
GO:1902904,negative regulation of supramolecular fiber organization,-2.815986994301389,-4.461091260828524,-3.6874207435729414
GO:0006979,response to oxidative stress,-2.1690830314040057,-3.3253833602806733,-3.522522608537514
R-MMU-2187338,Visual phototransduction,-3.0666486939446638,-2.942096747155502,-3.050489296179323
GO:0007568,aging,-3.042038528429077,-2.868515318261316,-3.0194463122826187
R-MMU-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),-2.55250558710745,-2.432291431461336,-2.5368890645603086
GO:0044057,regulation of system process,-4.162724610892117,-6.597843393137617,-2.8979350645306545
WP2075,Alzheimer's disease,-4.490996248313151,-5.564612089173169,-2.221925370872222
mmu04260,Cardiac muscle contraction,-8.001690514296875,-12.003608575654038,-6.62812342736387
GO:0098662,inorganic cation transmembrane transport,-7.358147830059262,-9.618558113799864,-6.439678245085955
GO:0046034,ATP metabolic process,-11.474520702174908,-20.601398656735753,-16.82118757561557
